+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Radiotherapy of prostatic cancer at the loco-regional stage: therapeutic results and prognostic factors

Radiotherapy of prostatic cancer at the loco-regional stage: therapeutic results and prognostic factors

Bulletin du Cancer. Radiotherapie 81(3): 196-205

The present study concerns 140 patients with loco-regional prostatic cancer, treated with external beam irradiation at the CRLC Val-d'Aurelle in Montpellier, France, between 1982 and 1988, with a minimum of 54 months follow-up. The local control after radiotherapy is 78.6%, all stages and histological grades combined. The median overall survival is 114 months and the median disease-free survival 59 months. The most frequent modality of treatment failure is metastatic disease, isolated (32.8%) or combined to local relapse (10%). The rate of urinary intolerance symptoms during treatment was 87.1 and 80.6% for the digestive ones. The late urinary complications and sequellae rate was 21.4% for the cystitis-type and 12.9% for post-radiotherapy urethral strictures; the latter has imposed in 2/3 of cases one or more trans-urethral resections that never showed pathological signs of recurrence. Digestive complications and sequellae occurred in 31.3% of the patients; in the latter group there were two internal digestive fistulae which needed surgical treatment and three postradiotherapeutic stenosis of the anal canal. The prognostic factors revealed by statistical analysis are clinical stage, pathological grade for overall and disease-free survival, age for overall survival and trans-urethral resection for disease-free survival, the latter being equally a risk factor for cystitis-type complications and urethral strictures.

(PDF emailed within 1 workday: $29.90)

Accession: 044135612

Download citation: RISBibTeXText

PMID: 7702903

Related references

Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer. Geburtshilfe und Frauenheilkunde 75(7): 710-718, 2015

Loco-regional recurrence following surgery of breast carcinoma: prognostic factors and therapeutic consequences. Schweizerische Medizinische Wochenschrift 118(52): 1976-1981, 1988

Prognostic factors for loco-regional failure in early stage (I and II) squamous cell carcinoma of the gingivobuccal complex. European Archives of Oto-Rhino-Laryngology 267(7): 1135-1140, 2010

Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. International Journal Of Radiation Oncology Biology Physics. 28(2): 355-362, 1994

Recurrence of stage I endometrial cancer: effect of prognostic factors on therapeutic results. Geburtshilfe und Frauenheilkunde 51(4): 267-271, 1991

7 - Terapia Nella Malattia In Progressione E Metastatica. Tumori 104(2_suppl): S27-S31, 2018

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer. Bmc Cancer 5(): 62-62, 2005

Loco-regional recurrences after mastectomy in breast cancer: Prognostic factors and implications for postoperative irradiation. Radiotherapy & Oncology 50(3): 267-275, March, 1999

Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease. RadioTherapy and Oncology 96(2): 199-203, 2010

Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncologica 43(4): 396-403, 2004

18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: association of loco‑regional SUVmax with classical prognostic factors. Quarterly Journal of Nuclear Medicine and Molecular Imaging 58(1): 66-73, 2014

Classical prognostic factors for survival and loco-regional control in breast cancer patients treated with radical mastectomy alone. Acta Oncologica (stockholm). 33(7): 759-765, 1994

Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study. Bmc Cancer 12(): 542-542, 2013

An analysis of prognostic factors in patients with prostatic cancer after hormone therapy and radiotherapy. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 84(11): 1975-1979, 1993